The Tri-Modal Biopharmaceutical Architecture
Four years of proprietary deeptech engineering by Fortem Biosciences have created a unified pharmaceutical operating system. By fusing generative de novo design, knowledge graph repurposing, and solid-state formulation AI, we bypass the conventional multi-billion-dollar trial bottleneck.
DiscoveraAI™
DiscoveraAI leverages conditional generative diffusion architectures, DTPred AI target prediction, and multi-modal transformers to explore chemical latent space (over 10^60 small molecules) and targeted biologics. Unlike brute-force virtual screening, DiscoveraAI designs de novo chemical entities that simultaneously optimize pocket affinity, synthesizability, and drug-like ADMET profiles.
Technical Specifications:
ReviveAI™ (SCALEX)
ReviveAI is our clinical-grade, computational drug repurposing enterprise platform. Traditional drug repurposing relies on serendipity or basic phenotypic screens. ReviveAI models the human biological interactome as a multi-relational heterogeneous knowledge graph (1.8M nodes, 42M biological edges) and applies node-level contrastive GNNs with bi-encoder architectures.
Technical Specifications:
> Query Target: CHIT1 (Chitinase-1 Macrophage Biomarker)
> Evaluating Cross-Graph Cosine Similarity across 4,200 Approved APIs...
Cosine Similarity: 0.9412 [P < 10^-8]
Indication Match: Amyotrophic Lateral Sclerosis (ALS)
Validated in In Vitro Microglial Polarization Assays
> Patent Non-Infringement Cleared (Freedom-to-Operate)
Enformis™
90% of promising drug candidates fail or incur multi-year delays due to poor formulation, low aqueous solubility, or rapid thermal degradation. Enformis is our latest breakthrough: a fine-tuned ChemBERTa solid-state formulation risk predictor. It forecasts thermal onset degradation (Tonset ±3.8°C), hydrolysis pathways, and excipient compatibility matrices with Bayesian active learning precision.
Technical Specifications:
100% Offline & HIPAA Isolated
Our enterprise clusters operate with zero external telemetric dependencies, guaranteeing proprietary clinical and molecular IP remains air-gapped and protected.
NVIDIA High-Throughput Compute
Accelerated with NVIDIA L4 Tensor Core GPUs and CUDA 13.0, running millions of chemical inferences in fractions of a second.
FDA 21 CFR Part 11 Audit Trail
Every inference, scoring iteration, and candidate triaging event is cryptographically logged to fulfill stringent regulatory electronic submission mandates.